Simplification Therapy with Once-Daily Didanosine, Tenofovir and Efavirenz in HIV-1-Infected Adults with Viral Suppression Receiving a More Complex Antiretroviral Regimen: Final Results of the EFADITE Trial

Ana Barrios(Hospital Universitario Infanta Sofía), Vicente Estrada(Instituto de Salud Carlos III), Vincent Soriano(Fundación Instituto Valenciano de Oncología), Bonaventura Clotet(Universitat de Vic - Universitat Central de Catalunya), Víctor Asensi(Baylor College of Medicine), Dolores Morales(Hospital Universitario Virgen Macarena), Pablo Labarga, Peré Domingo(Hospital de Sant Pau), Eugènia Negredo(Universitat de Vic - Universitat Central de Catalunya), Jesús Santos(Hospital Clínico Universitario Virgen de la Victoria)
Antiviral Therapy
October 1, 2005
10.1177/135965350501000708
Cited by 20

Related Papers

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
|JAMA|2021|728
Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
|AIDS|2002|443